http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0071060-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D521-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
filingDate 1982-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1986-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1986-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0071060-B1
titleOfInvention 6-(4-(omega-(1-imidazolyl)-alkyl)-phenyl)-3-oxo-2,3,4,5-tetrahydro-pyridazines and their acid-addition salts, process for their preparation and pharmaceutical compounds containing them
abstract The invention relates to new 6-{4-( omega -(1-imidazolyl)-alkyl)-phenyl}-3-oxo-2,3,4,5-tetrahydro-pyridazines having the general formula I <IMAGE> I and acid addition salts thereof, and to a process for the treatment of inflammatory, atherosclerotic and thromboembolic diseases especially in humans.
priorityDate 1981-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20403219
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236163115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20403220
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236163156
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236200527
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18185437
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236163382
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236166826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236164811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20403223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466465717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466531903
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236164828
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20403224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397450
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21990225
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70475140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236165733
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20403225
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414233
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13116734
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236166039
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20403226
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13116735
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236166137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232920682
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID242935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409913
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13116736
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236166176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231792613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228874867
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7416
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13116737
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236166404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467388469
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20403215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467388785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70474986
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13116733
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236160635

Total number of triples: 60.